Bio-Rad Laboratories (BIO) Income from Continuing Operations (2016 - 2025)
Bio-Rad Laboratories (BIO) has disclosed Income from Continuing Operations for 17 consecutive years, with 720000000.0 as the latest value for Q4 2025.
- Quarterly Income from Continuing Operations rose 200.59% to 720000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 759900000.0 through Dec 2025, up 141.2% year-over-year, with the annual reading at 759900000.0 for FY2025, 141.2% up from the prior year.
- Income from Continuing Operations for Q4 2025 was 720000000.0 at Bio-Rad Laboratories, up from 341900000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 3928033000.0 in Q3 2021, with the low at 3367347000.0 in Q1 2022.
- Average Income from Continuing Operations over 5 years is 54742250.0, with a median of 87594000.0 recorded in 2023.
- The sharpest move saw Income from Continuing Operations crashed 444.52% in 2022, then soared 514.75% in 2024.
- Over 5 years, Income from Continuing Operations stood at 1565304000.0 in 2021, then surged by 152.88% to 827769000.0 in 2022, then crashed by 57.75% to 349736000.0 in 2023, then crashed by 304.67% to 715800000.0 in 2024, then soared by 200.59% to 720000000.0 in 2025.
- According to Business Quant data, Income from Continuing Operations over the past three periods came in at 720000000.0, 341900000.0, and 317800000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.